All < Article List

Kerendia–SGLT-2 combo offers new standard for diabetic kidney disease management: experts
Hospital Kim Yun-mi 10.23 13:46
Wegovy ushers in double-digit weight loss era, redefining metabolic disease treatment
Hospital Kim Yun-mi 10.23 13:28
Boston Scientific’s TheraSphere reshapes liver cancer care in Korea as radioembolization eclipses chemo
Device/ICT Kim Ji-hye 10.23 13:15
University hospital heads warn health ministry takeover could weaken education, research roles
Hospital Kim Eun-young 10.23 11:20
Part-time positions key to improving senior doctor system, says NMC head
Hospital Kwak Sung-sun 10.23 10:49
LG Chem enters IVF treatment biz through partnership with Japan’s Kitazato
Pharma Lee Han-soo 10.23 10:00
CHA Vaccine shifts focus to homegrown shingles shot, files phase 2, and seeks partners
Pharma Kim Ji-hye 10.22 18:04
Organ transplant surgeries concentrated in Seoul metro region reduce their speed and efficiency
Hospital Kim Kyoung-Won 10.22 17:48
HK inno.N completes P3 trial for new indication of GERD drug K-CAB
Pharma Lee Han-soo 10.22 17:35
Share of early-stage lung cancer patients advised for radiation therapy instead of surgery increases. Why?
Hospital Kim Kyoung-Won 10.22 17:32
Humedix hosts a field tour for its Brazilian partner
Pharma Park Gi-taek 10.22 16:57
‘Jaqbo’s efficacy and safety confirmed in multiple patient groups in actual clinical practice’
Pharma Park Gi-taek 10.22 16:33
Myongji Hospital and the National Theater agree to cooperate for win-win ties of art and healthcare
Hospital Park Gi-taek 10.22 16:30
Severance Hospital to host national cerebral palsy registry performance meeting
Hospital Lee Han-soo 10.22 14:27
Civic group urges to end pilot telemedicine program, citing it as a ‘failure’
Policy Kim Jung-hyun 10.22 14:22
Chong Kun Dang spins off Archela as a unit focused on developing and testing drug candidates
Pharma Kim Ji-hye 10.22 14:17
Drug regulator came under fire for controversy over ₩200 billion in annual non-reimbursed anticancer injections
Pharma Park Gi-taek 10.22 14:15
MSD’s 21-valent adult pneumococcal vaccine wins Korea nod as ACIP lowers adult use to 50 and older
Pharma Kim Ji-hye 10.22 13:06
[ESMO 2025] Hanmi Pharm targets solid tumors with ‘EZH1/2 dual inhibitor’
Pharma Hong Sook 10.22 12:44
[ESMO 2025] Lunit's ‘AI response prediction’ solution highlights global competitiveness in cancer treatment
Device/ICT Hong Sook 10.22 12:34

상단영역

본문영역

All articles 목록 ( 총 : 21,030 )

기사목록 보기 형태

Kerendia–SGLT-2 combo offers new standard for diabetic kidney disease management: experts

Wegovy ushers in double-digit weight loss era, redefining metabolic disease treatment

Boston Scientific’s TheraSphere reshapes liver cancer care in Korea as radioembolization eclipses chemo

University hospital heads warn health ministry takeover could weaken education, research roles

Part-time positions key to improving senior doctor system, says NMC head

LG Chem enters IVF treatment biz through partnership with Japan’s Kitazato

CHA Vaccine shifts focus to homegrown shingles shot, files phase 2, and seeks partners

Organ transplant surgeries concentrated in Seoul metro region reduce their speed and efficiency

HK inno.N completes P3 trial for new indication of GERD drug K-CAB

Share of early-stage lung cancer patients advised for radiation therapy instead of surgery increases. Why?

Humedix hosts a field tour for its Brazilian partner

‘Jaqbo’s efficacy and safety confirmed in multiple patient groups in actual clinical practice’

Myongji Hospital and the National Theater agree to cooperate for win-win ties of art and healthcare

Severance Hospital to host national cerebral palsy registry performance meeting

Civic group urges to end pilot telemedicine program, citing it as a ‘failure’

Chong Kun Dang spins off Archela as a unit focused on developing and testing drug candidates

Drug regulator came under fire for controversy over ₩200 billion in annual non-reimbursed anticancer injections

MSD’s 21-valent adult pneumococcal vaccine wins Korea nod as ACIP lowers adult use to 50 and older

[ESMO 2025] Hanmi Pharm targets solid tumors with ‘EZH1/2 dual inhibitor’

[ESMO 2025] Lunit's ‘AI response prediction’ solution highlights global competitiveness in cancer treatment